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The pathology of inclusion body myositis (IBM) involves an inflammatory response and 𝛽-amyloid deposits in muscle fibres. It
is believed that MAP kinases such as the ERK signalling pathway mediate the inflammatory signalling in cells. Further, there
is evidence that autophagic activity plays a crucial role in the pathogenesis of IBM. Using a well established in vitro model of
IBM, the autophagic pathway, MAP kinases, and accumulation of 𝛽-amyloid were examined. We demonstrate that stimulation
of muscle cells with IL-1𝛽 and IFN-𝛾 led to an increased phosphorylation of ERK. The ERK inhibitor PD98059 diminished the
expression of proinflammatorymarkers as well as the accumulation of 𝛽-amyloid. In addition, IL-1𝛽 and IFN-𝛾 led to an increase of
autophagic activity, upregulation of APP, and subsequent accumulation of 𝛽-sheet aggregates. Taken together, the data demonstrate
that the ERK pathway contributes to formation of 𝛽-amyloid and regulation of autophagic activity in muscle cells exposed to
proinflammatory cell stress. This suggests that ERK serves as an important mediator between inflammatory mechanisms and
protein deposition in skeletal muscle and is a crucial element of the pathology of IBM.
1. Introduction
Inclusion bodymyositis (IBM) is the most common acquired
myopathy in patients over 50 years [1]. The disease pathol-
ogy is characterized by degenerative and immune-mediated
mechanisms acting in concert [2]. One can find an upreg-
ulation of various proinflammatory chemokines as well as
cytokines and an accumulation of aberrant proteins such as
𝛽-amyloid [2]. So far, the precise interplay between degener-
ation and inflammation is not entirely understood.
Exposure of muscle cells to the proinflammatory media-
tors IL-1𝛽 and IFN-𝛾 leads to subsequent accumulation of 𝛽-
amyloid [3].Mimicking a chronic inflammatory environment
with concomitant degenerative aggregates, this setting is used
as an in vitro model for IBM.
A complex network of intracellular and extracellular sig-
nalling mechanisms is thought to influence this relationship.
Beside cell stress, macroautophagy was described to play an
important role in the pathogenesis of IBM [4].We have previ-
ously shown that TNF-𝛼 induces macroautophagy in muscle
cells resulting in accumulation of 𝛽-amyloid [5, 6].
Autophagy is well preserved in cells to maintain recycling
of either misfolded or damaged proteins and cell organelles
like mitochondria [7]. There are at least three different types
of autophagy: (i) chaperone-mediated autophagy, (ii) micro-
autophagy, and (iii) macroautophagy. The latter is the best
studied so far and it includes the formation of double-mem-
braned organelles surrounding cytosolic material, named
autophagosomes. After fusion with lysosomes, the cargo gets
degraded.The process of macroautophagy (hereafter referred
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to as autophagy) can be induced by different stimuli, includ-
ing starvation, cell stress, and stimulation by different cyto-
kines and chemokines [8]. Furthermore, it was suggested that
autophagy might be involved in clearance of misfolded pro-
teins and impaired autophagy was reported in degenerative
muscle diseases [9].
Proinflammatory stimuli alter transcriptional programs
and can shape intracellular processes through activation of
various signal cascades [10]. In this context, it was shown that
especially the mitogen activated kinase ERK (extracellular
signal regulated kinase) is involved in muscle fibre differen-
tiation and inflammatory signalling. Furthermore, activated
ERK was shown to be present in IBM muscles and ERK
deposits were found in vacuoles [11].
In the present study, we use an in vitro model for IBM
to investigate the interrelationship of proinflammatory cell
stress, autophagy, and MAP kinase signalling in muscle cells.
2. Materials and Methods
2.1. Cell Culture. Human muscle cells from the cell line
CCL136 (ATCC; American Type Culture Collection,Manassas,
VA) were cultured in Dulbecco’s modified Eagle medium
supplemented with 10% fetal calf serum (FCS; Biochrom,
Berlin, Germany), 1% penicillin/streptomycin (Biochrom,
Berlin, Germany), and 1% L-glutamine (Invitrogen, Karl-
sruhe, Germany) at 37∘C in a humidified atmosphere of 5%
CO
2
. CCL136 cells stably transfected with a GFP-Atg8/LC3
fusion construct were used for autophagy experiments. Cells
seeded in chamber slides and culture wells were exposed
to the inflammatory cytokines IFN-𝛾 (300U/mL) and IL-1𝛽
(20 ng/mL) in serum-free X-vivo medium (Cambrex Bio Sci-
ence, Walkersville, USA) in duplicate. To regulate autophagy,
chloroquine (50𝜇M, Sigma, St. Louis, USA), 3-methyladenine
(3MA, Sigma, St. Louis, USA), and rapamycin (1 𝜇g/mL,
Sigma, St. Louis, USA) were used. For signalling pathway
analysis, CCL136 cells were stimulated in the presence of
the ERK/p42/44 inhibitor PD98059. Experiments were ter-
minated after 24 or 48 hours and cells were analyzed using
fluorescence microscopy.
2.2. Immunocytochemistry, Thioflavin-S-Fluorescence, and
Propidium Iodide Staining. For fluorescent staining, cultured
CCL136 cells were seeded in 8-chamber slides (Nunc, Roche-
ster, USA) and fixed in 4% paraformaldehyde (Electron Mic-
roscopy Sciences, Hatfield, USA) for 10 minutes at room temp-
erature, followed by further fixation inmethanol at −20∘C for
10 minutes. Cells were incubated with mouse anti-𝛽-amyloid
(clone 6E10 from Covance/HISS Diagnostics, Freiburg, Ger-
many) and rabbit anti-APP (R&D, Minneapolis, USA) at
10mg/mL for 24 hours at 4∘C. Secondary antibodies such as
goat anti-mouse and goat anti-rabbit conjugated to Alexa 594
(Molecular Probes/Invitrogen, Carlsbad, USA) were used for
detection via fluorescence microscopy.
Amyloid aggregation was stained employing 1% thio-
flavin-S (Sigma, St. Louis, USA) in distilledH
2
O for 5minutes
at room temperature. Nuclei were counterstained with 4,6-
diamidino-2-phenylindole (0.5 𝜇g/mL; Invitrogen/Molecular
Probes, Carlsbad, USA) for 1 minute; cells were mounted in
FluoromountG (ElectronMicroscopy Sciences,Hatfield,USA).
For propidium iodide (PI) staining, unfixed cells were
incubated at a final concentration of 2𝜇g/mL PI (Invitrogen,
Carlsbad, USA) for 20 minutes at 37∘C and washed with PBS.
Cells were mounted in Moviol (Calbiochem, San Diego, CA).
Fluorescencemicroscopywas performed on a Zeiss Axiophot
microscope (Zeiss, Goettingen, Germany), using appropriate
filters for green (488 nm), red (594 nm), and blue (350 nm)
fluorescence. Image acquisitionwas carried outmaking use of
a cooledCCDdigital camera (Retiga 1300Qimaging, Burnaby,
Canada) and ImagePro MDA 5.1 software. For quantitative
assessment, a greyscale analysis was performed using ImageJ
software (ImageJ, NIH, USA) and values are represented as
arbitrary units.
2.3. Western Blotting. CCL136 cells were lysed in lysis buffer
(20mM Hepes, 150mM NaCl, 2mM EDTA, 1% NP40,
pH 7.9) containing protease inhibitors (Roche, Mannheim,
Germany). Proteins were separated by 12% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and transferred to
a nitrocellulose membrane (Schleicher & Schuell, Dassel, Ger-
many). Blocking was done with 1% skimmed milk in TBS for
30 minutes. Subsequently, membranes were incubated over-
night at 4∘C with primary antibody anti-LC3 (mouse, dil-
uted 1 : 3000; Nanotools, Teningen, Germany). Horseradish
peroxidase-conjugated goat anti-mouse antibodies (Jack-
son Immuno Research, Suffolk, UK) were used as sec-
ondary reagents. For signal detection, the SuperSignal West
Pico Chemiluminescence Substrate Kit (Thermo Scientific,
Waltham, USA) was used, following the supplier’s protocol.
2.4. Statistics. Unpaired 𝑡-test and Grubbs’ test for exclusion
of outliers were calculated using GraphPad Prism version 7.0
(GraphPad Software) with ∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 <
0.001 as significant values.
3. Results
3.1. IL-1𝛽 and IFN-𝛾 Induce Autophagy in Muscle Cells. To
analyze autophagic activity in an in vitro model system for
IBM, stably transfected LC3-GFP-CCL136 cells were exposed
to IL-1𝛽 and IFN-𝛾. Under these proinflammatory condi-
tions, autophagic activity was upregulated as indicated via
detection of LC3-II by immunocytochemistry and west-
ern blotting (Figure 1). To visualize autophagosome forma-
tion, autophagosome fusion with lysosomes was blocked by
chloroquine. Blocking autophagosome formation using 3-
MA reduced autophagic activity in cells stimulatedwith IL-1𝛽
and IFN-𝛾.
3.2. IL-1𝛽-Induced Upregulation of APP and Generation of
𝛽-Amyloid Are Mediated by Autophagy. Myoblasts were
exposed to IL-1𝛽 and IFN-𝛾, which led to upregulation of
APP and subsequent accumulation of 𝛽-amyloid and 𝛽-
sheet-rich proteins in thioflavin-S-staining (Figure 2). Upon
inhibition of autophagic activity by 3-MA, the APP signal
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Figure 1: IL-1𝛽 and IFN-𝛾 induced autophagy. (a) Immunofluorescence analysis revealed IL-1𝛽 and IFN-𝛾 induced accumulation of
autophagosomes in GFP-LC3-transfected rhabdomyosarcoma cells. Inhibition of autophagy was exerted by 3-MA treatment. Quantitative
greyscale analysis of LC3 fluorescence intensity of cells incubated with IL-1𝛽 and IFN-𝛾 was carried out using Image J software. Results
are calculated as mean of three independent experiments and statistical significance is indicated by ∗∗𝑝 < 0.01. (b) Western blotting:
autophagosome-associated LC3-II and free cytosolic LC3-I were distinguished by molecular weight (16 and 18 kDa, resp.). 48 hours exposure
of human rhabdomyosarcoma cells to IL-1𝛽 and IFN-𝛾 led to increased levels of LC3-II. One of three independent experiments with identical
results is shown. Greyscale analysis of the LC3-II signal was carried out using Image J software and results are shown as mean plus standard
error from three independent experiments. Statistical significance is indicated by ∗∗∗𝑝 < 0.001.
intensity was reduced and intracellular accumulation of 𝛽-
amyloid was diminished (Figure 2).
3.3. IL-1𝛽 and IFN-𝛾-Mediated Autophagy in Muscle Cells
Depends on ERK Phosphorylation. To evaluate the upstream
pathways activated in this chronic muscle inflammation
model, we investigated the phosphorylation of the mitogen
activated protein (MAP) kinases ERK, p38, and JNK via
immunoblotting. Stimulation of muscle cells with IL-1𝛽 and
IFN-𝛾 increased phosphorylation of ERK (Figure 3), indicat-
ing signalling through this pathway. Levels of phosphorylated
JNK and phosphorylated p38 were unaffected (data not
shown). Furthermore, a trend towards reduced production
of the proinflammatory chemokine CXCL-9 was noted upon
ERK inhibition.
3.4. ERK Inhibition Reduces Autophagy and Diminishes Amy-
loid Formation. To block signalling through the ERK path-
way, myoblasts were exposed to the ERK inhibitor PD98059.
Inhibition of ERK resulted in decreased accumulation ofmis-
folded proteins (Figure 4). Additionally, autophagic activity
was reduced under proinflammatory conditions by blocking
ERK signalling. Cell viability examined with PI staining
revealed increased cell death upon stimulation with IL-1𝛽
and IFN-𝛾, whilst PD98059 was able to significantly reduce
induction of cell death.
4. Discussion
We studied the regulation of autophagy and protein accumu-
lation in an in vitro model for proinflammatory related cell
stress in muscle cells. We demonstrate that IL-1𝛽 and IFN-
𝛾 induce autophagy, which mediates the generation of mis-
folded proteins. Furthermore, the ERK pathway was identi-
fied as the regulating element in proinflammatory conditions
(schematic overview in Figure 5). Previous studies report
that autophagy plays an important role in skeletal muscle
homeostasis [12]. Under physiological activity, autophagy is
thought to play a protective role, according to its function
clearing cellular debris and removing misfolded proteins
[13]. On the other hand, nonphysiological conditions lead to
muscle atrophy (high autophagic activity) or weakness and
degeneration (low activity) [14]. However, in our proinflam-
matorymodel, inhibition of autophagy led to a lower amount
of protein aggregates. The same effect was described in TNF-
𝛼 induced and autophagy-related accumulation of misfolded
proteins [6]. In conditions of enhanced cell stress, it is possi-
ble that overloading of the autophagic pathway leads to partial
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Figure 2: Autophagy-associated upregulation of𝛽-amyloid andAPP. Immunocytochemical analysis of humanmyoblasts whichwere exposed
to IL-1𝛽 and IFN-𝛾 for 48 hours displayed increased signals of thioflavin-S, 𝛽-amyloid, and APP. This was reversed after inhibition of
autophagy via 3-MA. Quantitative greyscale analysis was performed using Image J and results are shown as standard error of mean of three
independent experiments. ∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001.
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Figure 3: IL-1𝛽 and IFN-𝛾 effects are mediated via ERK sig-
nalling pathway. Immunoblotting analysis of human muscle cells
(CCL136) exposed to IL-1𝛽 and IFN-𝛾 and simultaneously treated
with increasing concentrations of the p42/44 (ERK) MAP kinase
inhibitor PD98059 for 24 hours. IL-1𝛽 and IFN-𝛾 led to increased
phosphorylation of ERK. Treatment with the ERK inhibitor
PD98059 resulted in a trend towards decreased protein levels of
CXCL-9. One of two experiments with identical results is shown.
protein turnover. In line with this hypothesis, Nogalska and
colleagues found that there is decreased lysosomal activity
in IBM, leading to an accumulation of autophagic vacuoles
[15]. On the other hand, induction of autophagy can exert
protective properties in noninflammatory myopathies [16].
In muscles from IBM patients, IL-1𝛽 and IFN-𝛾 are over-
expressed among other proinflammatory cytokines [17]. The
expression of IL-1𝛽 and IFN-𝛾 correlates with the expression
of 𝛽-amyloid-associated proteins in IBM muscles and in
vitro [3]. One mediator for such inflammatory cell stress
pathways in skeletal muscle has previously been identified
by our group: iNOS is upregulated under proinflammatory
conditions and subsequent production of NO promotes
the intracellular accumulation of 𝛽-amyloid [18]. Moreover,
the iNOS pathway appears to be directly related to the
phosphorylation of ERK as demonstrated by Bae et al. [19]:
reduction of ERK-phosphorylation in immobilized legs of
iNOS KO mice compared to wild type mice ameliorated the
skeletal muscle atrophy induced by immobilization.
We hypothesize that proinflammatory cytokines stimu-
late autophagic vacuole formation and fusion with lysosomes
through signalling via ERK.This was visualized by the lipida-
ted LC3-II turnover in IL-1𝛽 and IFN-𝛾 treated rhabdomyo-
sarcoma cells. ERK inhibition led to a decrease in autophagic
activity. However, in contrast to LC3-II turnover, APP deg-
radation in autolysosomes seemed to be incomplete and pro-
duce 𝛽-amyloid under these conditions. Accordingly, inhibi-
tion of ERK protected cells from accumulation of 𝛽-amyloid.
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Figure 4: ERK inhibition diminishes amyloid formation and reduces autophagy. Immunofluorescence analysis revealed an increase in
thioflavin-S fluorescence in human myoblasts incubated with IL-1𝛽 and IFN-𝛾 for 48 hours. This was reversed after inhibition of the
ERK pathway via PD98059. IL-1𝛽 and IFN-𝛾 induced accumulation of autophagosomes in GFP-LC3-transfected rhabdomyosarcoma cells.
Inhibition of the ERK pathway led to reduced autophagy. Quantitative greyscale analysis was performed using Image J and results are shown
as standard error of mean of three independent experiments. Exposure of humanmyoblasts to IL-1𝛽 and IFN-𝛾 led to an increased cell death,
demonstrated by propidium iodide (PI) staining. Treatment with the ERK inhibitor PD98059 partially prevented cell death. Quantitative
greyscale analysis was performed using Image J and results are shown as standard error of mean of three independent experiments. ∗𝑝 < 0.05
and ∗∗𝑝 < 0.01.
It is known that the ERK pathway can stimulate auto-
phagic activity through regulating Beclin-1 [20]. Further-
more, in ovarian cancer cells, the proteasome inhibitor borte-
zomib allowed fusion between lysosomes and autophago-
somes but modified the lysosomal cathepsin content of the
resulting autolysosomes [21]. ERK activation via phospho-
rylation was found to be responsible for this modification
of lysosomal degradation. This suggests impaired lysosomal
degradation in autolysosomes, despite elevated autophago-
some formation and maturation through activation of the
ERK pathway. Our findings suggest that impaired autolyso-
somal degradation still allows the breakdown of LC3-II but
leads to the production of 𝛽-amyloid from APP. Accordingly,
ERK-positive deposits were found in vacuolated fibres from
patients with IBM [22] and increased phosphorylation of
ERK was facilitated by autophagy stimulating conditions
[23].Thus, we postulate that proinflammatory stimuli induce
the activation of the ERK pathway, resulting in attenuated
autolysosomal degradation and the accumulation of mis-
folded partially degraded proteins like 𝛽-amyloid.
In this model system, the induction of autophagy with
rapamycin resulted in an even higher amount of protein
deposits. This phenomenon is discussed controversially in
the field: In one mouse-model for VCPmyopathy, autophagy
stimulation increased disease symptoms [24], whilst, in a
different VCP mouse, a decrease in protein aggregates was
noted upon treatment with rapamycin [25]. In addition, both
protective and detrimental effects of autophagy were also
reported in different mouse models for degenerative myo-
pathies like Duchenne muscular dystrophy [14]. These con-
troversial findings could be explained by the capacity of the
affected tissues to degrade the pathogenic proteins in these
models.We observed that LC3-II can still be efficiently turned
over in autolysosomes of IL-1𝛽 and IFN-𝛾 stimulated rhab-
domyosarcoma cells, whilst APP turnover was incomplete
and led to 𝛽-amyloid accumulation. Similarly, beneficial
effects of autophagy stimulation also require potent lysoso-
mal hydrolysis. If the respective degradation machinery is
attenuated by ERK-dependent reduction of lysosomal cath-
epsin content, increased autophagy may cause an imperfect
6 Mediators of Inflammation
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Figure 5:Model of regulation ofmacroautophagy in skeletal muscle
via IL-1𝛽 + IFN-𝛾 and ERK. Green arrows depict findings of the
present manuscript: IL-1𝛽 + IFN-𝛾 activates the ERK pathway.
Phosphorylated ERK contributes to an upregulation of autolyso-
somal turnover, which is followed by accumulation of protein.
Previously knownpathways aremarked by grey arrows, including an
upregulation of APP upon exposure to IFN-𝛾 + IL-1𝛽 and followed
by generation of𝛽-amyloid and accumulation of protein. It is known
that macroautophagy contributes to production of 𝛽-amyloid.
degradation with an increasing accumulation of protein
aggregates.
5. Conclusion
In summary, our study demonstrates a profound upregu-
lation of autophagic activity in skeletal muscle upon IFN-
𝛾 plus IL-1𝛽, which resulted in accumulation of misfolded
proteins and degeneration. The data provide a mechanistic
explanation for the known interaction between inflammation
and degeneration in IBM.
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